Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns

NCT00955487 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Bronchopulmonary Dysplasia

Interventions

DRUG: Inhaled Nitric Oxide (iNO)
DRUG: Nitrogen (placebo)

Sponsor

University of Colorado, Denver

Collaborators

[object Object]